Private insurance claim lines for sexually transmitted diseases (STDs) rose 76% nationally from 2007 to 2018, according to a new study of STDs from FAIR Health, a national, independent nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information. The study results, which are being released in the form of an infographic, are based on analysis of data from FAIR Health’s comprehensive repository of over 30 billion private healthcare claim records—the largest in the country.
According to the Centers for Disease Control and Prevention (CDC), combined cases of syphilis, gonorrhea and chlamydia, the three most commonly reported STDs, reached an all-time high in the United States in 2018. FAIR Health’s findings shed new light on this growing public health issue.
Among the results of the FAIR Health study:
Claim lines with STD diagnoses, as a percentage of all medical claim lines, increased nationally 76 percent from 2007 to 2018, but the increase was even greater in rural areas—98%, compared to 77% in urban areas (FIGURE 1).
Source: FAIR Health
The 4 STD diagnoses whose associated claim lines had the greatest percent increase from 2007 to 2018 as a percentage of all medical claim lines were:
The age groups most associated with STDs in 2018 varied by the specific disease. The age groups that accounted for the largest share of claim lines were:
From 2007 to 2018, claim lines with gonorrhea diagnoses as a percentage of all medical claim lines by gender increased 326% in males compared to 47% in females (FIGURE 2).
In individuals over 60 years of age, hepatitis B was the STD that showed the highest percent increase in claim lines from 2007 to 2018, and claim lines for hepatitis B increased more in the over 60 cohort (149%) than in any other age group.
The age groups with the greatest increase in claim lines from 2007 to 2018 were:
It is central to FAIR Health’s mission to use our vast repository of claims data to research public health concerns and support such research by others. We hope this information brings greater clarity to the growing problem of STDs.
For the FAIR Health infographic on STDs, click here.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More